// App-Quantinova.ai

AB0055 (2018) : Hydroxychloroquine inhibits soluble cd154 production through ca2+ and pkc signalling pathway

Researchers

Presenter

  • C.H. Tung

Principal Investigators

  • J.-M. Hsu

  • M.-C. Lu

  • N.-S. Lai

Medical Centers

  • Division of Allergy, Immunology and Rheumatology, Dalin Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Chiayi, Taiwan, Republic of China, Chia-yi, Taiwan, Province of China

Locations

  • China

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • Cluster of Differentiation 4

Drug/Treatment

  • Hydroxychloroquine

  • lonomycin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved